Educational Content: This article is for informational purposes only. The products described are research compounds not approved for human therapeutic use. Always consult a qualified healthcare professional before use.
What is BPC-157?
BPC-157 — or Body Protection Compound 157 — is a stable synthetic pentadecapeptide consisting of 15 amino acids. It is derived from a protective protein found in human gastric juice, where it was first identified and studied for its role in mucosal protection and healing.
Unlike many research peptides that are analogs of naturally occurring hormones, BPC-157 is considered an "orphan peptide" in the sense that no direct endogenous equivalent has been identified in circulation. Its stability is one of its most notable properties: BPC-157 remains effective across a broad range of conditions, including exposure to gastric acid, which makes it one of the more extensively studied peptides in oral and injectable formulations.
What the Research Shows
Preclinical research on BPC-157 has explored a wide range of applications. The published literature — predominantly animal studies — has examined its effects on:
Tissue Repair & Wound Healing: Multiple rodent studies have documented accelerated healing of tendons, ligaments, muscle, and skin tissue. Researchers have proposed that BPC-157 may upregulate growth hormone receptor expression and modulate the nitric oxide (NO) system, both of which play roles in angiogenesis and wound healing.
Gut & Gastrointestinal Wellness: Given its origin in gastric juice, BPC-157's effects on the GI tract are among its most studied properties. Research has examined its role in protecting the gastric mucosa, supporting intestinal anastomosis healing, and modulating the gut-brain axis.
Inflammation Modulation: Several studies have explored BPC-157's influence on the inflammatory response, with researchers noting its apparent ability to modulate pro-inflammatory cytokines without broad immunosuppression.
Neurological Applications: Animal models have investigated BPC-157 in the context of traumatic brain injury, neuroprotection, and dopaminergic function — though this remains an early area of research.
It is important to note that the overwhelming majority of published research involves animal models. Human clinical trials for BPC-157 are limited, and its mechanisms of action in humans are not fully established.
Proposed Mechanisms of Action
Researchers have proposed several mechanisms through which BPC-157 may exert its effects:
Nitric Oxide (NO) System Modulation: BPC-157 appears to interact with the NO system, which plays a critical role in vascular tone, inflammation, and tissue repair. Some researchers hypothesize that this interaction underpins many of BPC-157's observed effects.
Growth Factor Upregulation: Preclinical studies have noted increases in the expression of growth hormone receptor (GHR) in tendon fibroblasts treated with BPC-157, suggesting a possible role in accelerating tissue regeneration.
Angiogenesis Support: BPC-157 has been observed to support the formation of new blood vessels in healing tissue, which is essential for delivering nutrients and oxygen to repair sites.
Gut-Brain Axis Interaction: Some researchers have proposed that BPC-157 interacts with dopamine and serotonin pathways, which may explain observed effects on mood and neurological function in animal models.
Forms & Administration
BPC-157 is available in two primary forms for research purposes:
Injectable (Subcutaneous): The lyophilized (freeze-dried) vial form requires reconstitution with bacteriostatic water prior to use. This is the most commonly studied administration route in the published literature.
Oral: Some researchers have studied BPC-157 administered orally, noting that its stability in gastric acid may preserve bioavailability. This is a less established route compared to subcutaneous injection.
For those working with injectable BPC-157, proper reconstitution and storage are critical. Our Peptide Reconstitution & Storage Guide in the Wellness Library provides step-by-step guidance.
Storage & Handling
Lyophilized BPC-157 vials should be stored at room temperature (15–25°C), away from direct light and moisture, until reconstituted. Once reconstituted with bacteriostatic water, the solution should be refrigerated (2–8°C) and used within 28–30 days.
Avoid freezing reconstituted peptide solutions, as repeated freeze-thaw cycles can degrade peptide integrity. Always use a clean, sterile technique when drawing from the vial.
Important Considerations
As with all research compounds, several important considerations apply to BPC-157:
Not approved for human therapeutic use: BPC-157 is not approved by Health Canada, the FDA, or any other regulatory body for the prevention, treatment, or cure of any disease or condition.
Preclinical data is not clinical data: The majority of published research has been conducted in animal models. Results from preclinical studies do not always translate directly to human outcomes.
Consult a healthcare professional: If you are considering incorporating any research peptide into your wellness routine, we strongly recommend consulting with a qualified healthcare professional who can assess your individual circumstances.
Quality matters: Peptide purity varies significantly between suppliers. All Stay Healthy peptide products undergo independent third-party testing for identity, purity, and potency — certificates of analysis are available upon request.